Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$6.63 - $10.69 $1.33 Million - $2.14 Million
200,348 New
200,348 $1.62 Million
Q2 2022

Aug 15, 2022

SELL
$6.99 - $10.0 $1.05 Million - $1.5 Million
-150,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.26 - $10.7 $1.09 Million - $1.61 Million
150,000 New
150,000 $1.19 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $583M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Kent Lake Capital LLC Portfolio

Follow Kent Lake Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kent Lake Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kent Lake Capital LLC with notifications on news.